Filed
Pursuant to Rule 424(b)(5)
Registration
No. 333-297729
Amendment
No. 1 dated September 29, 2026
To
Prospectus Supplement dated September 25, 2026
(To
Prospectus dated August 10, 2026)
Up
to $100,000,000
BOXABL
Inc.
Class
A Common Stock
This
Amendment No. 1 to Prospectus Supplement (this “Amendment”) amends the prospectus supplement of BOXABL Inc. (the “Company,”
“we,” “us” or “our”), dated September 25, 2026 and filed with the Securities and Exchange Commission
(the “SEC”) on September 28, 2026 pursuant to Rule 424(b)(5) under the Securities Act of 1933, as amended (the “Prospectus
Supplement”), relating to the offer and sale from time to time of shares of our Class A common stock, par value $0.0001 per share
(the “Common Stock”), having an aggregate offering price of up to $100,000,000 pursuant to the ATM Sales Agreement, dated
September 25, 2026, by and among the Company and Virtu Americas LLC, A.G.P./Alliance Global Partners, Cohen & Company Capital Markets,
a division of Cohen & Company Securities, LLC, Maxim Group LLC and Roth Capital Partners, LLC. This Amendment should be read in conjunction
with the Prospectus Supplement and the accompanying prospectus dated August 10, 2026 (the “Base Prospectus”), and is qualified
by reference thereto, except to the extent that the information herein amends or supersedes the information contained in the Prospectus
Supplement. This Amendment is not complete without, and may only be delivered or utilized in connection with, the Prospectus Supplement
and the Base Prospectus, including any amendments or supplements thereto.
This
Amendment is being filed solely to correct (1) the date on which our registration statement on Form S-3 (File No. 333-297729) was initially
filed with the SEC, which the Prospectus Supplement inadvertently stated as September 27, 2026 rather than July 27, 2026, and (2) certain
aggregate dollar amounts presented under the heading “Dilution,” consisting of our as-adjusted net tangible book value, the
increase in net tangible book value attributable to new investors, our pro forma net tangible book value after giving effect to the offering
and the effect of a $0.10 change in the assumed offering price, and to delete a typographical error in the dilution table. For ease of
reference, the section of the Prospectus Supplement under the heading “Dilution” is amended and restated in its entirety
in this Amendment to reflect these corrections, and the restated section set forth below supersedes and replaces that section of the
Prospectus Supplement in its entirety.
Except
as expressly set forth herein, this Amendment does not amend, update or otherwise modify the Prospectus Supplement or the Base Prospectus.
Investing
in our securities involves a high degree of risk. Before making an investment decision, please read the information under “Risk
Factors” beginning on page S-4 of the Prospectus Supplement, on page 4 of the Base Prospectus and under similar headings in
any amendment or supplement to the Prospectus Supplement or the Base Prospectus or in any filing with the SEC that is incorporated by
reference therein.
NEITHER
THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETERMINED
IF THIS PROSPECTUS SUPPLEMENT AND THE ACCOMPANYING PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL
OFFENSE.

| A.G.P. |
|
Cohen
& Company Capital Markets, a division of Cohen & Company Securities, LLC |
|
Maxim
Group LLC |
|
Roth
Capital Partners |
The
date of this Amendment No. 1 is September 29, 2026.
DILUTION
If
you invest in our Common Stock in this offering, your ownership interest will be immediately diluted to the extent of the difference
between the public offering price per share of our Common Stock and the as-adjusted net tangible book value per share of our Common Stock
after this offering.
Our
net tangible book value as of March 31, 2026 was approximately $47.7 million, or approximately $0.20 per share of Common Stock. Net tangible
book value per share is determined by dividing the net tangible book value (total tangible assets less total liabilities) by the number
of outstanding shares of Common Stock.
After
giving effect to the sale of our Common Stock in the aggregate amount of 25,125,628 at an assumed offering price of $3.98 per share,
the last reported sale price of our Common Stock on Nasdaq on September 23, 2026, and after deducting commissions and estimated offering
expenses payable by us, our as-adjusted net tangible book value as of March 31, 2026 would have been approximately $146.6 million, or
$0.55 per share of Common Stock. This represents an immediate increase in net tangible book value of $0.35 per share to our existing
stockholders and an immediate dilution in net tangible book value of $3.43 per share to new investors purchasing shares of our Common
Stock in this offering. The following table illustrates this per share dilution:
| Assumed
public offering price per share |
|
|
|
|
|
$ |
3.98 |
|
| Net
tangible book value per share as of March 31, 2026 |
|
$ |
0.18 |
|
|
|
|
|
| Increase
in net tangible book value per share attributable to new investors |
|
$ |
0.37 |
|
|
|
|
|
| Pro
forma net tangible book value per share after giving effect to this offering |
|
|
|
|
|
$ |
0.55 |
|
| Dilution
per share to new investors in this offering |
|
|
|
|
|
$ |
3.43 |
|
The
table above assumes, for illustrative purposes, that an aggregate of 25,125,628 shares of our Common Stock are sold at a price of $3.98
per share, the last reported sale price of our Common Stock on Nasdaq on September 23, 2026, for aggregate gross proceeds of approximately
$100,000,000. A $0.10 increase in the assumed offering price of $3.98 per share would increase our as-adjusted net tangible book value
per share after this offering by $0.01 and the dilution per share to new investors by $3.52, assuming the number of shares offered by
us, as set forth above, remains the same and after deducting commissions and estimated offering expenses payable by us. A $0.10 decrease
in the assumed offering price of $3.98 per share would decrease our as-adjusted net tangible book value per share after this offering
by $0.01 and the dilution per share to new investors by $3.34, assuming the number of shares offered by us, as set forth above, remains
the same and after deducting commissions and estimated offering expenses payable by us.
The
above discussion and table are based on 9,471,524 shares of our Common Stock and 232,083,710 shares of our Class B common stock, par
value $0.0001, outstanding as of September 23, 2026, and excludes shares issuable upon the exercise of outstanding stock options, the
exercise of outstanding warrants and the conversion of outstanding convertible securities. To the extent that any of these outstanding
securities are exercised or converted, or additional shares are issued, you may experience further dilution. In addition, we may choose
to raise additional capital due to market conditions or strategic considerations even if we believe we have sufficient funds for our
current or future operating plans. To the extent that additional capital is raised through the sale of equity or convertible securities,
the issuance of these securities could result in further dilution to our stockholders.